ASBPW

Aspire Biopharma Warrant
ASBPW

40 hedge funds and large institutions have $1.15M invested in Aspire Biopharma Warrant in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.12M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6K
2
+$1.7K
3
+$1.6K
4
PC
Periscope Capital
Ontario, Canada
+$1.25K
5
EFI
EHP Funds Inc
Canada
+$1.25K

Top Sellers

1
-$8.36K
2
-$4K
3
-$3.13K
4
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$1.5K
5
AA
AQR Arbitrage
Connecticut
-$181
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3.01K
27
$3K
28
$2.73K
29
$2.5K
30
$1.7K
31
$1.6K
32
$1.37K
33
$1.25K
34
$1K
35
$902
36
$751
37
$626
38
$626
39
$264
40
$1
41
–
42
–
1
2